|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Preliminary experience of helical tomotherapy for locally advanced pancreatic cancer显示文摘Radiotherapy for locally advanced pancreatic cancer is technically difficult and frequently associated with high-grade digestive toxicity.Helical tomotherapy(HT)is a new irradiation modality that combines megavoltage computed tomography imaging for patient positioning with intensity-modulated fan-beam radiotherapy.Its recent availability opens new fields of exploration for pancreatic radiotherapy as a result of its ability to tailor very well-defined dose distributions around the target volumes.Here,we report the use of HT in two patients with locally advanced pancreatic cancer. Doses to the bowel,kidneys and liver were reduced significantly,which allowed for excellent treatment tolerance without any high-grade adverse effects in either patient. | Cyrus Chargari Francois Campana Philippe Beuzeboc Sofia Zefkili Youlia M Kirova | 2009 | World Journal of Gastroenterology2009，15，35： | 5 |
| 2 | Multicenter randomized phase Ⅱ study of two schedules of docetaxel,estramustine,and prednisone versus mitoxantrone plus prednisone in patients with metastatic hormone-refractory prostate cancer显示文摘 | Oudard S Banu E Beuzeboc P | 2005 | J Clin Oncol2005，23，15： | 1 |
| 3 | Targeting HER2 in other tumor types显示文摘 | Scholl S Beuzeboc P Pouillart P | 2001 | Ann Oncol2001，12，1： | 1 |
| 4 | Phase II trial of consolidation docetaxel and samarium 153 in patients with bone metastases from castration resistant prostate eaneer显示文摘 | Fizazi K Beuzeboc P Lumbroso J | 2009 | J Clin Onco12009，27，15： | 1 |
| 5 | Pathologic response to short intensified taxane-free neoadjuvant chemotherapy in patients with highly proliferative operable breast cancer显示文摘 | LE TOURNEAU C DETTWILER S BEUZEBOC P | 2012 | Am J Clin Oncol2012，35，3： | 1 |
| 6 | Ifosfamide seven-day infusion for recurrent and cisplatin refractory ovarian cancer显示文摘 | Dorval T Soussain C Beuzeboc P | 1996 | J Infus Chemother1996，6，1： | 1 |
| 7 | Multicenter randomized phase II study of two schedules of docetaxel, estramustine,and prednisone versus mitoxantrone plus prednisone in patients with metastatic hormonerefraetory prostate cancer显示文摘 | Oudard S Banu E Beuzeboc P | 2005 | J Clin Oncol2005，23，15： | 1 |
| 8 | Targeting HER2 in oth-er tumor types显示文摘 | Scholl S Beuzeboc P Pouillart P | 2001 | Ann Oncol2001，12，： | 1 |
| 9 | Targeting HER2 in other tumor types显示文摘 | Scholl S Beuzeboc P Pouillart P | 2001 | Ann Oncol2001，12，11： | 1 |
| 10 | Targeting HER2 in other tumor types显示文摘 | Scholl S Beuzeboc P Pouillart P | 2001 | Ann Oncol2001，12，1： | 1 |
| 11 | Targeting HER-2 in other tumor types显示文摘 | Scholl S Beuzeboc P Pouillart P | 2001 | Ann Oncol2001，12，1： | 1 |
| 12 | Multicenter randomizedphase It study of two schedules of docetaxel, estramustine, andprednisone versus mitoxantrone plus prednisone in patients withmetastatic hormone-refractory prostate cancer显示文摘 | Oudard S Banu E Beuzeboc P et af | 2005 | J Clin Oncol2005，23，15： | 1 |
| 13 | Targeting Her-2 in other tumor types 显示文摘 | Scholl S Beuzeboc P Pouillart P | 2001 | Ann Oncol2001，12，1： | 1 |
| 14 | Double-blindedcontrolled study comparing clodronate versus placebo in patientswith breast cancer bone metastases显示文摘 | Tubiana-Hulin M Beuzeboc P Mauriac L | 2001 | Bull Cancer2001，88，： | 1 |
| 15 | Characteristics and outcome of 1755 operable breast cancers in women over 70 years of age显示文摘 | J.-Y. Pierga V. Girre V. Laurence B. Asselain V. Diéras M. Jouve P. Beuzeboc A. Fourquet C. Nos B. Sigal-Zafrani P. Pouillart | 2004 | The Breast2004，，5： | 1 |
| 16 | Herceptin, a monoclonal humanized antibody anti-HER-2: a major therapeutic progress in breast cancers overexpressing this oncogene? 显示文摘 | Scholl S Garau XS | 1999 | Bull Cancer1999，86，6： | 1 |
| 17 | Phase II trial of consolidation docetaxel and samarium-153in patients with bone metastases from castration-resistant prostate cancer显示文摘 | Fizazi K Beuzeboc P Lumbroso J | 2009 | J Clin Oncol2009，27，15： | 1 |
| 18 | Indications of Herceptin in breast cancer treatment显示文摘 | Beuzeboc P | 2004 | Gynecol Obstet Fertil2004，32，2： | 1 |
| 19 | Concurrent chemoradiotherapy for clinical stage T2 bladder cancer: report of a single institution显示文摘 | Micha?l Peyromaure Jer?me Slama Philippe Beuzeboc Dominique Ponvert Bernard Debré Marc Zerbib | 2004 | Urology2004，，1： | 1 |
| 20 | Double-blinded controlled study comparing clodronate versus placebo in patients with breast cancer bone metastases:显示文摘 | Tubiana-Hulin M Beuzeboc P Mauriac L | 2001 | Bull Cancer2001，88，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员